Ernst Berndt

Louis E. Seley Professor in Applied Economics
Professor of Applied Economics

Biography | Selected Publications

“Comparison of Stakeholder Metrics for Traditional and Adaptive Development and Licensing Approaches to Drug Development" with Lynn G. Baird, Mark R. Trusheim, Hans-Georg Eichler, and Gigi M. Hirsch,  Therapeutic Innovation & Regulatory Science, 47(4):474-483, July 2013.

“Defining and Quantifying the Use of Personalized Medicines” with Sean X. Hu, Murray L. Aitken, Arnold M. Epstein, and Mark R. Trusheim, Nature Reviews: Drug Discovery, online version published 29 November 2013, http://www.nature.com/nrd/journal/v12/n12/full/nrd4177.html?WT.ec_id=NRD-201312. Hard copy version to be published December 2013.

“How Quickly Do Physicians Adopt New Drugs? The Case of Antipsychotics” with Haiden A. Huskamp, Alistar J. O’Malley, Marcela Horvitz-Lennon, Anna Levine Taub and Julie M. Donohue, Psychiatric Services, 64(4):324-330, April 2013.

“Price Indexes for Clinical Trial Research: A Feasibility Study” with Iain M. Cockburn, National Bureau of Economic Research, Working Paper 18918, March 2013. Forthcoming, Monthly Labor Review

“Promotion of Prescription Drugs to Consumers and Providers, 2001-2010” with Rachel Kornfield, Julie Donohue and G. Caleb Alexander, PLOS ONE, 8(3):e55504. Doi:10.1371/journal.pone.0055504, published March 4, 2013.

“The Impact of Emerging Safety and Effectiveness Evidence on the Use of Physician-administered Drugs: The Case of Bevacizumab for Breast Cancer” with Rena Conti, Stacie B. Dusetzina, Ann C. Herbert, Haiden A. Huskamp and Nancy L. Keating, Medical Care, 51(7):622-627, July 2013.

“Uncertain prognosis for high-quality diagnostics: clinical challenges, economic barriers and needed reforms” with Mark R. Trusheim, M.J. Finley Austin and Carsten Rausch, Pharmacogenomics, (2013) 14(3):325-334. (2013)

“Vaccine Economics” in Anthony Culyer, ed., with Sean McElligott , Encyclopedia of Health Economics, San Diego, CA: Elsevier Inc., forthcoming 2013

“Winners and Losers From the Zaltrap Price Discount: Unintended Consequences?” with Rena Conti, Health Affairs Blog, available at http://healthaffairs.org/blog/2013/02/20/winners-and-losers-from-the-zaltrap-price-discount, posted February 20, 2013

“Economic Challenges and Possible Policy Actions to Advance Stratified Medicine” with Mark R. Trusheim, Personalized Medicine, 9(4):413-27, 2012.

 “Economic Challenges and Possible Policy Actions to Advance Stratified Medicine” with Mark R. Trusheim, Personalized Medicine, 9(4):413-27, 2012. 

“Pricing and Reimbursement in U.S. Pharmaceutical Markets” with Joseph P. Newhouse, Patricia M. Danzon and Sean N. Nicholson, eds., Chapter 8 in The Oxford Handbook on the Economics of the Biopharmaceutical Industry, New York: Oxford University Press, pp. 201-265, 2012. 

 “The Segmentation of Therapeutic Populations in Oncology” with Mark R. Trusheim, Health Management, Policy and Innovation, 1(1):19-34, October 2012. 

“The Segmentation of Therapeutic Populations in Oncology” with Mark R. Trusheim, Health Management, Policy and Innovation, 1(1):19-34, October 2012.

“The Unbundling of Advertising Agency Services: An Economic Analysis” with Mohammad Arzaghi, James C. Davis and Alvin J. Silk, Review E.R. Berndt, C.V - page 30 of Marketing Science, 10 (2012), Article 4. DOI:10.1515/1546-5616.1164. (2012)

“A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets” with Thomas G. McGuire and Joseph P. Newhouse, Forum for Health Economics & Policy, 14(2), Article 10, November 2011.

“Advance Market Commitment for Pneumococcal Vaccines: Moving from Theory to Practice” with Tania Cernuschi, Eliane Furrer, Nina Schwalbe, Andrew Jones and Susan McAdams, Bulletin of the World Health Organization, posted online 14 October 2011, ID: BLT.11.08770

An Overview of Henry Grabowski’s Scholarly Contributions (2011)

“Brand Loyalty, Generic Entry and  Price Competition in Pharmaceuticals in the Quarter Century after the 1984 Waxman-Hatch Legislation” with Murray L. Aitken, International Journal of the Economics of Business, 18(2):177-201, July 2011. 

”Diffusion of New Drugs in the Post-TRIPS Era”with Nathan Blalock and Iain M. Cockburn,  International Journal of the Economics of Business, 18(2):203-24, July 2011. 

“Economic Perspectives On The Advance Market Commitment For Pneumococcal Vaccines” with Christopher M. Snyder, Mark William Begor, Health Affairs, 30(8):1508-17, August 2011.

“Medicare Part D at Age Five: What Has Happened to Seniors’ Prescription Drug Prices?” with Murray L. Aitken, Report by the IMS Institute for Healthcare Informatics, July 2011, 12 pp. 

“Quality Adjustment for Healthcare Spending on Chronic Disease: Evidence from Diabetes Treatment, 1999-2009" American Economic Review, 101(3):206-211, May 2011. with Nilay D. Shah, Karen N. Eggleston, Steven A. Smith and Joseph P. Newhouse

“Quantifying Factors for the Success of Stratified Medicine” with Mark R Trusheim, Breon Burgess, Sean Xinghua Hu, Theresa Long, Steven D. Averbuch, Aiden A. Flynn, Alfons Lieftucht, Abhijit Mazumder, Judy Milloy, Peter Shaw, David Swank, Jian Wang, Federico Goodsaid and Michael C. Palmer, Nature Reviews: Drug Discovery, 10:817-33, November 2011.

“Bridging the Gap: Improving Clinical Development and the Regulatory Pathways for Health Products for Neglected Diseases” with Thomas J. Bollyky and Iain M. Cockburn, Clinical Trials, published online 25 November 2010, DOI: 10.1177/1740774510386390

“Characterizing  Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?” with Mark R. Trusheim and Murray L. Aitken, Forum for Health Economics & Policy, Manuscript 1200, June 2010, 48 pp. 

“Hedonic Price Indexes for Personal Computer Operating Systems and Productivity Suites” with Alan G. White, Jaison R. Abel and Cory W. Monroe, Annales d’Economie et de Statistique, Special Issue in Memory of Zvi Griliches, 79/80:787-807, 2005 (actually published June 2010). 

Pricing and Reimbursement in U.S. Pharmaceutical Markets (2010)

“The Net Value of Health Care for Patients with Type 2 Diabetes, 1997 to 2005” with Karen N. Eggleston, Nilay D. Shah, Steven A. Smith, Amy E. Wagie, Arthur R. Williams, Jerome H. Grossman, Kirsten Hall Long, Ritesh Banerjee and Joseph P. Newhouse. Annals of Internal Medicine. 151(6):386-393, September 2009.

Energy Prices and Productivity Trends in the Canadian Manufacturing Sector, 1957-76 : Some Exploratory Results. Ottawa: Minister of Supply and Service Canada, 1981.

View complete list of publications (PDF) >>

 

Contact Information
Office: E62-518
Tel: (617) 253-2665
Fax: (617) 258-6786
Support Staff
Name: Lucy Sonner
Tel: (617) 253-8318

General Expertise
Applied economics; Applied mathematics; Database marketing; Drug and biological regulatory strategies; Econometrics; Economics; Emerging markets; Global economics; Globalization; Health management; Industrial economics; Industrial organization; Management of technology; Medical decision making; Microeconomics; Price fixing; Probability; Research and development; Workplace health